Advertisement

Systemic Nitric Oxide Production in Human Malaria

II. Analysis of Mononuclear Cell Nitric Oxide Synthase Type 2 Antigen Expression
  • Jocelyn R. Saunders
  • Mary A. Misukonis
  • J. Brice Weinberg
  • Nicholas M. Anstey
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 72)

Abstract

As described in Chapter 42, niric oxide (NO) is synthesized from the amino acid l-arginine by the actions of a family of enymes, the NO synthases (NOS), each isoform of which is encoded by a separate gene. Two NOS isoforms are calcium-dependent and constitutively expressed and produce low levels of NO: NOS1 (neuronal NOS or nNOS), which is found mostly in neurons and skeletal muscle, and NOS3 (endothelial NOS or eNOS), which is found mostly in endothelial cells. NOS1 is critical for neurotransmission and learning, and NOS3 regulates vascular tone and adhesion of circulating cells. Inducible NOS (iNOS or NOS2) is transcriptionally induced by proinflammatory cytokines (such as tumor necrosis factor-α [TNF-α] and interferon-γ [IFN-γ]) and microbial products (e.g., lipoplysaccharide [LPS]). iNOS is calciumindependent, expressed by many cell types (especially mononuclear phagocytes, hepatocytes, chondrocytes and smooth muscle cells) and is responsible for high output NO production (1-3). While initial studies showed that iNOS expression within mouse macrophages resulted in high-output NO production, until recently there was doubt as to whether human macrophages were capable of producing NO. There is now clear evidence however that human monocytes and tissue macrophages can express iNOS and produce NO both in vitro and in vivo (3), including evidence from malaria-exposed Tanzanian children (4).

Keywords

Peripheral Blood Mononuclear Cell iNOS Expression Biorad Protein Assay Peripheral Blood Mononuclear Cell Sample Freeze Cell Pellet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bogdan, C. (1998) The multiplex functions of nitric oxide in (auto)immunity. J. Exp. Med. 187, 1361–1365.CrossRefPubMedGoogle Scholar
  2. 2.
    Moncada, S. and Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002–2012.CrossRefPubMedGoogle Scholar
  3. 3.
    Weinberg, J. (1998) Nitric oxide production and nitric synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4, 557–591.PubMedGoogle Scholar
  4. 4.
    Anstey, N. M., Weinberg, J. B., Hassanali, M. Y., Mwaikambo, E. D., Manyenga, D., Misukonis, M. A., et al. (1996) Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184, 557–567.CrossRefPubMedGoogle Scholar
  5. 5.
    Bollag, D., Rozycki, M., and Edelstein, S. (1996) Protein Methods. Wiley, New York.Google Scholar
  6. 6.
    Harlow, E. and Lane, D. (1988) Antibodies. A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NYGoogle Scholar

Copyright information

© Humana Press, Inc., Totowa, NJ 2002

Authors and Affiliations

  • Jocelyn R. Saunders
    • 1
  • Mary A. Misukonis
    • 1
  • J. Brice Weinberg
    • 2
  • Nicholas M. Anstey
    • 1
  1. 1.Tropical Medicine and International Health UnitMenzies School of Health ResearchDarwinAustralia
  2. 2.Division of Hematology, Department of MedicineDuke UniversityDurham

Personalised recommendations